Pharmacodynamics, pharmacokinetics, safety, and tolerability of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in patients with type 2 diabetes (Q34835217)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pharmacodynamics, pharmacokinetics, safety, and tolerability of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in patients with type 2 diabetes |
scientific article |
Statements
1 reference
Pharmacodynamics, pharmacokinetics, safety, and tolerability of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in patients with type 2 diabetes (English)
1 reference
Jessica E Matthews
1 reference
Murray W Stewart
1 reference
Erika H De Boever
1 reference
Robert L Dobbins
1 reference
Rebecca J Hodge
1 reference
Susan E Walker
1 reference
M Claire Holland
1 reference
Mark A Bush
1 reference
Albiglutide Study Group
1 reference
23 September 2008
1 reference
1 reference
Identifiers
1 reference